123 related articles for article (PubMed ID: 33180393)
1. Assessment of Complement Regulatory Proteins CD55 and CD59 on Erythrocytes in Beta-Thalassemia Major Patients.
Zahran AM; Shaltout AS; Hamada IH; Mohammed AM; Abo Elgheet AM; Elsayh KI
Egypt J Immunol; 2020 Jan; 27(1):109-118. PubMed ID: 33180393
[TBL] [Abstract][Full Text] [Related]
2. Expression of CD55 on red blood cells of β-thalassemia patients.
Obaid JM; Abo El-Nazar SY; Ghanem AM; El-Hadidi AS; Mersal BH
Hemoglobin; 2014; 38(5):339-44. PubMed ID: 25026028
[TBL] [Abstract][Full Text] [Related]
3. The effect of splenectomy on complement regulatory proteins in erythrocytes in β-thalassemia major.
Kurtoğllu AU; Koçtekin B; Kurtoğlu E; Yildiz M
Arch Med Sci; 2019 Jan; 15(1):191-195. PubMed ID: 30697270
[TBL] [Abstract][Full Text] [Related]
4. Compensation of CD55 Underexpression on Red Blood Cells of β-Thalassemia Major Patients.
Obaid JM; Abo El-Nazar SY; Ghanem AM; El-Hadidi AS; Mersal BH
Hemoglobin; 2015; 39(3):184-9. PubMed ID: 25897480
[TBL] [Abstract][Full Text] [Related]
5. Altered Expression Levels of CD59, but Not CD55, on Red Blood Cells in Stored Blood.
Al-Faris L; Al-Humood S
Med Princ Pract; 2019; 28(4):361-366. PubMed ID: 30844815
[TBL] [Abstract][Full Text] [Related]
6. [Expression of CD55 and CD59 in chronic rhinosinusitis and its significance].
Xia L; Wang Y; Gao W; Gao H
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Dec; 49(12):1021-3. PubMed ID: 25623871
[TBL] [Abstract][Full Text] [Related]
7. Altered Expression Pattern of CD55 and CD59 on Red Blood Cells in Anemia of Chronic Kidney Disease.
Al-Faris L; Al-Humood S; Behbehani F; Sallam H
Med Princ Pract; 2017; 26(6):516-522. PubMed ID: 28957817
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA sensitizes tumor cells to complement attack in vitro.
Geis N; Zell S; Rutz R; Li W; Giese T; Mamidi S; Schultz S; Kirschfink M
Curr Cancer Drug Targets; 2010 Dec; 10(8):922-31. PubMed ID: 20879979
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of complement regulators CD55 and CD59 on peripheral blood cells in patients with EAHEC O104:H4 infection.
Dammermann W; Schipper P; Ullrich S; Fraedrich K; Schulze Zur Wiesch J; Fründt T; Tiegs G; Lohse A; Lüth S
PLoS One; 2013; 8(9):e74880. PubMed ID: 24086391
[TBL] [Abstract][Full Text] [Related]
10. Expression and regulation by interferon-gamma of the membrane-bound complement regulators CD46 (MCP), CD55 (DAF) and CD59 in gastrointestinal tumours.
Schmitt CA; Schwaeble W; Wittig BM; Meyer zum Büschenfelde KH; Dippold WG
Eur J Cancer; 1999 Jan; 35(1):117-24. PubMed ID: 10211099
[TBL] [Abstract][Full Text] [Related]
11. Deficiency of red cell bound CD55 and CD59 in patients with systemic lupus erythematosus.
Richaud-Patin Y; Pérez-Romano B; Carrillo-Maravilla E; Rodriguez AB; Simon AJ; Cabiedes J; Jakez-Ocampo J; Llorente L; Ruiz-Argüelles A
Immunol Lett; 2003 Aug; 88(2):95-9. PubMed ID: 12880676
[TBL] [Abstract][Full Text] [Related]
12. Trimeresurus flavoviridis (habu snake) venom induces human erythrocyte lysis through enzymatic lipolysis, complement activation and decreased membrane expression of CD55 and CD59.
Yamamoto C; Tsuru D; Oda-Ueda N; Ohno M; Hattori S; Kim ST
Pharmacol Toxicol; 2001 Oct; 89(4):188-94. PubMed ID: 11881969
[TBL] [Abstract][Full Text] [Related]
13. Relative Contribution of Cellular Complement Inhibitors CD59, CD46, and CD55 to Parainfluenza Virus 5 Inhibition of Complement-Mediated Neutralization.
Li Y; Parks GD
Viruses; 2018 Apr; 10(5):. PubMed ID: 29693588
[TBL] [Abstract][Full Text] [Related]
14. Frequent expression of complement resistance factors CD46, CD55, and CD59 on gastrointestinal cancer cells limits the therapeutic potential of monoclonal antibody 17-1A.
Juhl H; Helmig F; Baltzer K; Kalthoff H; Henne-Bruns D; Kremer B
J Surg Oncol; 1997 Mar; 64(3):222-30. PubMed ID: 9121154
[TBL] [Abstract][Full Text] [Related]
15. Detection of CD55- and/or CD59-deficient red cell populations in patients with lymphoproliferative syndromes.
Meletis J; Terpos E; Samarkos M; Meletis C; Apostolidou E; Komninaka V; Korovesis K; Mavrogianni D; Boutsis D; Variami E; Viniou N; Konstantopoulos K; Loukopoulos D
Hematol J; 2001; 2(1):33-7. PubMed ID: 11920231
[TBL] [Abstract][Full Text] [Related]
16. Treatment with recombinant human erythropoietin (rHuEpo) in a patient with paroxysmal nocturnal haemoglobinuria: evaluation of membrane proteins CD55 and CD59 with cytofluorometric assay.
Astori C; Bonfichi M; Pagnucco G; Bernasconi P; Lazzarino M; Orlandi E; Bernasconi C
Br J Haematol; 1997 Jun; 97(3):586-8. PubMed ID: 9207404
[TBL] [Abstract][Full Text] [Related]
17. Protease-modified erythrocytes: CD55 and CD59 deficient PNH-like cells.
Yuan FF; Bryant JA; Fletcher A
Immunol Cell Biol; 1995 Feb; 73(1):66-72. PubMed ID: 7539403
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD59, a regulator of the membrane attack complex of complement, on human skeletal muscle fibers.
Navenot JM; Villanova M; Lucas-Héron B; Malandrini A; Blanchard D; Louboutin JP
Muscle Nerve; 1997 Jan; 20(1):92-6. PubMed ID: 8995588
[TBL] [Abstract][Full Text] [Related]
19. Expression levels of CD47, CD35, CD55, and CD59 on red blood cells and signal-regulatory protein-alpha,beta on monocytes from patients with warm autoimmune hemolytic anemia.
Barros MM; Yamamoto M; Figueiredo MS; Cançado R; Kimura EY; Langhi DM; Chiattone CS; Bordin JO
Transfusion; 2009 Jan; 49(1):154-60. PubMed ID: 18954403
[TBL] [Abstract][Full Text] [Related]
20. Complement regulatory molecules on human myelin and glial cells: differential expression affects the deposition of activated complement proteins.
Koski CL; Estep AE; Sawant-Mane S; Shin ML; Highbarger L; Hansch GM
J Neurochem; 1996 Jan; 66(1):303-12. PubMed ID: 8522968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
